QUIDELORTHO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.68 USD | -2.73% |
|
+7.56% | -42.09% |
| May. 08 | Transcript : QuidelOrtho Corporation, Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | Earnings Flash (QDEL) QUIDELORTHO CORPORATION Posts Q1 Revenue $711M, vs. Street Est of $695.1M | MT |
Presenter SpeechCasey Woodring (Analysts)Great. Well, thank you, everybody, for coming today. ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Calendar
2024-05-14
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
42.68
USD
Average target price
54.4
USD
Spread / Average Target
+27.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -42.09% | 2.85B | |
| -17.65% | 18.51B | |
| +23.15% | 1.95B | |
| +3.08% | 1.72B | |
| +28.27% | 1.26B | |
| -11.16% | 1.02B | |
| -17.21% | 950M | |
| +0.07% | 777M | |
| -23.17% | 643M | |
| +11.79% | 518M |
- Stock Market
- Equities
- QDEL Stock
- News QuidelOrtho Corporation
- Transcript : QuidelOrtho Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09